Pharmajournalist.com Website Review

pfizer and biontech propose expansion of pivotal covid-19 vaccine trial. bayer collaborates with recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases. gilead sciences, inc. and immunomedics announced that the companies have entered into a definitive agreement…. pfizer and biontech propose expansion of pivotal covid-19 vaccine trial. pfizer inc. and biontech se announced that they have submitted an amended protocol to the u.s. food and drug…. harbour biomed and hualan genetic announced collaboration to develop multiple innovative…. harbour biomed (hbm), a global, clinical-stage, innovative biopharmaceutical company announced a strategic…. boehringer and click thera*eutics enter into collaboration to develop and commercialize…. boehringer ingelheim and click thera*eutics announced they have entered into a collaboration for the development… global contract packaging organisation (cpo), tjoapack is investing in its automated packaging capabilities to meet…. humanized chicken antibody technology to drive next generation of integral…. integral molecular announces the development of humanized chicken antibody technology (hcat) and the incorporation…. bird rock bio files ind application for phase 2 study of nimacimab for treatment of renal diseases. bird rock bio, inc., a clinical stage biopharmaceutical company, announced that the company has filed an investigational new drug (ind). vasopharm completes patient enrollment for phase 3 traumatic brain injury trial (nostra) vasopharm gmbh, a privately held biopharmaceutical company focusing on novel thera*eutics for the treatment of cerebrovascular diseases,. neuroptika announces enrollment of first patient in phase 2 clinical trial for dry eye disease. neuroptika announced that the first patient was enrolled in a phase 2 clinical trial of nro-1 for the treatment of dry eye disease. nro-1 is. farxiga met primary endpoint in landmark phase iii dapa-hf trial for the treatment of patients with….